Name
Osaühing Perearst Hiie Karelson
Registry code
10894004
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.10.2002 (21)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86211 - Provision of general medical treatment
410 890 €
43 844 €
11%
3 000 €
(estimate is approximate)
207 648 €
4
Submitted
No tax arrears
21%
19%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Hiie Karelson 28.11.1971 (52) | 100% - 2 556.00 EUR | Board member | Direct ownership | |
| Ermitex Grupp OÜ 10205223 | - | - | - | Founder |
| 2019 19.05.2020 | 2020 28.06.2021 | 2021 02.06.2022 | 2022 26.06.2023 | 2023 24.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 244 606 € | 273 276 € | 279 982 € | 335 764 € | 410 890 € |
| Net profit (loss) for the period | 12 344 € | 51 262 € | 67 049 € | 44 869 € | 43 844 € |
| Profit Margin | 5% | 19% | 24% | 13% | 11% |
| Current Assets | 13 052 € | 4 599 € | 38 673 € | 197 798 € | 81 067 € |
| Fixed Assets | 76 882 € | 116 754 € | 129 000 € | 0 € | 144 962 € |
| Total Assets | 89 934 € | 121 353 € | 167 673 € | 197 798 € | 226 029 € |
| Current Liabilities | 9 110 € | 9 467 € | 8 738 € | 13 994 € | 18 381 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 80 824 € | 111 886 € | 158 935 € | 183 804 € | 207 648 € |
| Employees | 4 | 4 | 4 | 4 | 4 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 15 950.89 € | 17 155.6 € | 5 |
| 2023 Q4 | - | 18 443.93 € | 18 057.59 € | 5 |
| 2023 Q3 | - | 21 382.49 € | 22 410.57 € | 5 |
| 2023 Q2 | - | 18 857.64 € | 19 600.35 € | 6 |
| 2023 Q1 | - | 18 690.07 € | 19 257.38 € | 6 |
| 2022 Q4 | - | 17 352 € | 17 791.53 € | 6 |
| 2022 Q3 | - | 16 375.01 € | 16 829.69 € | 6 |
| 2022 Q2 | - | 11 988.34 € | 11 939.53 € | 5 |
| 2022 Q1 | - | 12 648.56 € | 13 137.73 € | 4 |
| 2021 Q4 | - | 10 143.49 € | 9 799.57 € | 4 |
| 2021 Q3 | - | 12 772.92 € | 12 943.03 € | 3 |
| 2021 Q2 | - | 9 504.68 € | 9 314.53 € | 4 |
| 2021 Q1 | - | 11 859.25 € | 11 719.87 € | 3 |
| 2020 Q4 | - | 13 866.55 € | 12 772.92 € | 4 |
| 2020 Q3 | - | 13 255.14 € | 13 483.34 € | 4 |
| 2020 Q2 | - | 9 021.17 € | 9 161.57 € | 4 |
| 2020 Q1 | - | 11 915.22 € | 12 384.41 € | 4 |
